2010-05-01
Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia
Publication
Publication
Abstract: We describe the validation of a serum-based test developed by Rules-Based Medicine which can be used to help confirm the diagnosis of schizophrenia. In preliminary studies using multiplex immunoassay profiling technology, we identified a disease signature comprised of 51 analytes which could distinguish schizophrenia (n = 250) from control (n = 230) subjects. In the next stage, these analytes were developed as a refined 51-plex immunoassay panel for validation using a large independent cohort of schizophrenia (n = 577) and control (n = 229) subjects. The resulting test yielded an overall sensitivity of 83% and specificity of 83% with a receiver operating characteristic area under the curve (ROC-AUC) of 89%. These 51 immunoassays and the associated decision rule delivered a sensitive and specific prediction for the presence of schizophrenia in patients compared to matched healthy controls.
| Additional Metadata | |
|---|---|
| , , | |
| hdl.handle.net/1765/23084 | |
| Biomarker Insights | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Schwartz, E., Izmailov, R., Spain, M., Barnes, A., Mapes, J., Guest, P., … Bahn, S. (2010). Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia. Biomarker Insights. Retrieved from http://hdl.handle.net/1765/23084 |
|
